CD8A and myeloid sarcoma: Several studies have demonstrated selective enrichment of EBV-specific CD8 T cells but not CD8 T cells recognizing cytomegalovirus (CMV) or candidate MS-associated autoantigens, in the cerebrospinal fluid (CSF) of MS patients (54, –, 57), suggesting activation of a localized cytotoxic T-cell response toward EBV.